BioIVT

BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialise in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples.

Our PHASEZERO^® Research Services team works collaboratively with clients to provide target and biomarker validation, phenotypic assays to characterise novel therapeutics, clinical assay development and in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE^®.

 

Contact details:

North America & Asia Pacific

T +1 516 483 1196

Europe, Middle East & Africa

T +44 (0) 1444 250010

Product hub: CD34+ haematopoietic stem cells: One cell type, multiple viable sources

Whitepaper: Disease state primary cells bring verification and validation studies closer to real-world results

Whitepaper: Isolation of tumour infiltrating lymphocytes from dissociated tumour cells

Case study: Shipping media for fresh tissue

Whitepaper: Recommendations to consider when sourcing human biospecimens

Guide: Questions to ask your human biological specimen provider

eBook: Drop by drop: the future of liquid biopsy

How to block trogocytosis and improve CAR T-cell therapy

A “hot” issue: TGF -β and checkpoint inhibitor resistance

Providing new hope for rare disease using non-viral gene therapy

The promise of cell therapy: scaling up a new treatment paradigm for hearing loss

Challenges and opportunities: lessons learned in developing potential gene therapy cures

Leveraging a dual technology platform to develop gene therapies for a range of rare diseases

Drug Target Review Cell & Gene Therapy ebook

An equal seat at the table for AI in pharmaceutical discovery

Video: Ethical and regulatory use of biospecimens in the EU

Video: Multiplex IHC and digital analysis for immuno-oncology